The aim of the present study was to evaluate the phenotypic characteristics of the macrolidelincosamide-streptogramin B (MLS B ) resistance in Staphylococcus aureus and coagulase-negative staphylococci (CNS) strains isolated from various clinical samples in our hospital. The study was conducted on 516 Staphylococcus isolates isolated from various clinical samples in Microbiology Laboratory of Diyarbakir State Hospital between January, 2009 and December, 2009. After the identification of microorganisms via conventional methods and the evaluation of their methicillin resistance profile, disk approximation test was performed using erythromycin (15 µg) and clindamycin (2 µg) disks in order to determine MLS B resistance phenotypes. Of 516 Staphylococcus isolates, 208 were determined to be S. aureus and 308 were CNS. The MLS B resistance of isolates was 56.2%, whereas the resistance due to the efflux pump was determined to be 3.5%. The MLS B resistance phenotype was determined in 38% of S. aureus strains and 68.5% of CNS strains. The presence of MLS B resistance was determined to be higher in methicillin-resistant group (74.7%) compared to the methicillin-susceptible group (23.9%). While constitutive MLS B resistance (cMLS B ) and inducible MLS B resistance (iMLS B ) were determined in 48.9 and 19.1% of methicillin-resistant S. aureus strains, respectively, these rates were 2.6 and 10.5% for methicillin-susceptible strains, respectively. The rate of constitutive resistance was determined to be 41.5% in methicillin resistant CNS, whereas the rate of inducible resistance was determined to be 35.9%. In methicillin-susceptible CNS group, cMLS B and iMLS B resistances were determined to be 17.6 and 23%, respectively. The cMLS B phenotype was more common among methicillin-resistant S. aureus and CNS group, whereas iMLS B phenotype was more common among methicillin-susceptible S. aureus strains. In conclusion, we suggest that the determination and reporting of the presence of inducible resistance is of great importance regarding the success of therapy; therefore, it would be beneficial to use D test in routine antibiogram studies.
INTRODUCTION
The change in Gram-positive bacteria that cause infections and the increase in their antimicrobial resistances accompany the problems related to the *Corresponding author. E-mail: drhakantemiz@gmail.com. Tel: +90 4122580060/2129 or +90506 3366444. Fax: +90412 2580046. treatment options (Hancock, 2005) . Staphylococcus aureus and coagulase-negative staphylococci (CNS) are the most important causes of hospital-acquired and community-acquired infections among Gram-positive bacteria.
Today, increased prevalence of methicillin resistance to staphylococci is a significant problem, so alternative antibiotics should be investigated (Patel et al., 2006) . Macrolides and streptogramins are considered among these alternative treatment options. Although the macrolide, lincosamide, and streptogramin B antibiotics are chemically different, they have similar effects on the inhibition of bacterial protein synthesis (Patel et al., 2006; Cetin et al., 2008) . Therefore, the genes causing resistance to one of the macrolide-lincosamidestreptogramin B (MLSB) antibiotics may develop a resistance to others.
The resistance to these antibiotics usually develops via modification by methylation (23S ribosomal RNA methylase-mediated ribosomal modification coded by erm gene) of the ribosomal target or via the active efflux pump encoded by macrolide streptogramin resistance (msrA) gene. When resistance to erythromycin develops due to active efflux pump system, the isolates that are resistant to erythromycin are susceptible to clindamycin, whereas these isolates may be resistant to clindamycin in the case that macrolide resistance develops due to ribosomal methylation (Roberts et al., 1999) .
The ribosomal resistance that commonly affects the MLS B group antibiotics may be either constitutive (cMLS B ) or inducible (iMLS B ). While the isolates with constitutive resistance are resistant to all MLS B group antibiotics, the inducible resistance develops due to the presence of strong inducers of methylase synthesis, such as erythromycin and azithromycin (Lim et al., 2002; Fiebelkorn et al., 2003) .
Owing to the fact that cross resistance can develop in the microorganisms that are resistant to one of the MLS B group antibiotics, investigating the resistance phenotypes is of great importance for the success of antibiotic treatment. Therefore, in the present study, it was aimed to evaluate the phenotypic characteristics of the MLS B resistance in S. aureus and CNS strains isolated from various clinical samples in Diyarbakir State Hospital.
MATERIALS AND METHODS
The present study was conducted on 516 staphylococcus isolates isolated from different samples obtained from either hospitalized or ambulatory patients in Diyarbakir State Hospital between January, 2009 and December, 2009. The isolates that had been re-isolated from the same patient were excluded from the study. Microorganisms were identified via conventional methods such as colony morphology, gram staining, catalase test, coagulase test and DNAse test.
The methicillin resistance of staphylococcus isolates, as well as the MLSB resistance phenotypes, was investigated in accordance with the criteria of the Clinical Laboratory Standards Institute (CLSI) (2009), via disk diffusion method using Sensi-Disc (BectonDickinson Microbiology Systems, Franklin Lakes, NJ, USA). For this purpose, the bacterial suspension equivalent to the 0.5 McFarland turbidity standard was spread over the surface of Mueller-Hinton agar (Oxoid Ltd., London, England). Cefoxitin (30 µg) and oxacillin (1 µg) disks were used for the investigation of methicillin resistance, whereas erythromycin (15 µg) and clindamycin (2 µg) disks were used for the investigation of MLSB resistance. The plates were evaluated after being incubated in aerobic conditions at 35 o C for 18 to 24 h. Double disk approximation test was used to determine the MLSB 
RESULTS
Of 516 staphylococcus isolates, 208 (40.3%) were S. aureus and 308 (59.7%) were CNS. The MLS B resistance was determined in 290 (56.2%) isolates; whereas efflux pump phenotype was determined in 18 (3.5%) isolates. The distribution of resistance phenotypes for S. aureus and CNS is presented in Table 1 .
In the present study, the data concerning CNS and S. aureus strains were grouped according to their resistance status against methicillin, and these groups were statistically analyzed according to their MLS B resistance status. The results of the analyses are presented in Table  2 .
There was no significant difference between methicillinresistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCNS) groups regarding the presence of MLS B resistance (χ 2 = 3.046, p = 0.081). However, when the MLS B resistant isolates were divided into two groups according to their resistance types as iMLS B [S. aureus: n = 18 (19.1%), CNS n = 84 (35.9%)] and cMLS B [S. aureus: n = 46 (48.9%), CNS n = 97 (41.5%)], a significant difference was noted between MRSA and MRCNS strains in iMLS B group (χ 2 = 9.186, p = 0.01).
iMLS B resistance was detected in 21 S. aureus and 78 CNS strains when the distance between of the erythromycin and clindamycin disks were 26 mm. However, it was detected in 30 S. aureus and 101 CNS strains when the distance was shortened to 15 mm.
DISCUSSION
Macrolides and lincosamides are the antibiotics commonly used in the treatment of staphylococcal infections (Patel et al., 2006; Maravic, 2004) . Streptogramins have similar effects with these two antibiotic groups. This similarity between the antibiotics may lead to microorganisms to gain resistance to the antibiotics in the (100) 94 (100) 114 (100) 208 (100) 234 (100) 74 (100) 308 (100) S. aureus: Staphylococcus aureus; CNS: coagulase-negative staphylococci; MR: methicillin-resistant; MS: methicillin-susceptible; MLSB: macrolide-lincosamide-streptogramin B; cMLSB: constitutive MLSB resistance; iMLSB: inducible MLSB resistance. same group. Therefore, investigating the resistance phenotypes is of great importance regarding the success of the antibiotic treatment. MLS B resistance in Staphylococcus has been investigated in many studies. In the studies from various regions, it was observed that the rates of MLS B resistance changed from 7.2% (10) to 88.9% (Lina et al., 1999) in S. aureus strains, whereas it varied between 21.5% (Merino-Díaz et al., 2007) and 82.0% (Fiebelkorn et al., 2003) in CNS strains.
In the previous studies, it has been reported that MLS B resistance both in S. aureus and CNS strains differs by geographic region, hospitals and patient groups. While the rate of MLS B resistance in CNS strains was reported to be lower than that in S. aureus strains (Lim et al., 2002; Lina et al., 1999) , Aktas et al. (2007) found the MLS B resistance to be similar in CNS and S. aureus groups. However, in some studies, also in the present study, MLS B resistance in CNS strains was found to be higher than that in S. aureus strains (Patel et al., 2006; Fiebelkorn et al., 2003; Merino-Díaz et al., 2007; Gonullu et al., 2009; Yılmaz et al., 2007; Delialioglu et al., 2005) .
In the present study, as well as in the previous studies, it was determined that the rate of inducible resistance phenotype in methicillin-susceptible S. aureus (MSSA) strains was higher than the rate of constitutive resistance phenotype (Cetin et al., 2008; Lim et al., 2002; Otsuka et al., 2007; Uyanık et al., 2009; Steward et al., 2005; Schmitz et al., 2000) . On the contrary, Shrestha et al. (2009) found the rate of constitutive resistance phenotype higher than the rate of inducible resistance phenotype in MSSA strains. Similar differences have been reported for methicillin-susceptible CNS (MSCNS). In the present study, the rate of constitutive resistance was found 17.6%, whereas the rate of inducible resistance was 23%; in consistent with the results of numerous studies (Cetin et al., 2008; Lim et al., 2002; Lina et al., 1999; YIlmaz et al., 2007) . On the other hand, Diaz et al. (Merino-Díaz et al., 2007) found that the rates of constitutive and inducible resistance phenotypes were equal, whereas some other investiga-tors determined the rate of the constitutive resistance phenotype to be higher (Aktas et al., 2007; Gonullu et al., 2009; Delialioglu et al., 2005) .
In the present study, the rate of constitutive resistance was higher than the inducible resistance both in MRSA and in MRCNS strains. However, in the some studies, the constitutive resistance has been determined more commonly, but the inducible resistance has been reported to be higher in other studies both in some others are reporting that is higher both in MRSA (Uyanık et al., 2009; Shrestha et al., 2009 ) and MRCNS strains (Cetin et al., 2008; Lim et al., 2002; Denis et al., 2002; Dogruman et al., 2008) .
Based on the results of the present study, it can be suggested that the resistance rates may differ by regions or hospitals. Antibiotic use and the origin (hospital or community) of the isolated strains are important factors Ozbek et al. 3295 for the development of resistance. Nonetheless, the development of resistance to antibiotics may vary according to hospitals, regions and countries due to various factors (Koksal, 2006) . Therefore, many factors should be taken into consideration while investigating the differences between the resistance rates. In this study, the investigation of iMLS B by D-test showed that; when the distance between the disks was 15 mm, the induction of clindamycin resistance by erythromycin occurred clearly better than 26 mm.
In conclusion, we consider that the determination of the presence of inducible resistance is of great importance for the success of the treatment and that the use of D-test in routine antibiogram analyses would be beneficial.
